Reduced anxious behavior in mice lacking the CCK2 receptor gene. (Q47972586)

7 February 2018

title

Reduced anxious behavior in mice lacking the CCK2 receptor gene. (English)

1 reference

7 February 2018

author name string

Yukiko Horinouchi

1

1 reference

7 February 2018

Jotaro Akiyoshi

2

1 reference

7 February 2018

Aki Nagata

3

1 reference

7 February 2018

Hirotaka Matsushita

4

1 reference

7 February 2018

Takashi Tsutsumi

5

1 reference

7 February 2018

Koichi Isogawa

6

1 reference

7 February 2018

Tetsuo Noda

7

1 reference

7 February 2018

Haruo Nagayama

8

1 reference

7 February 2018

language of work or name

English

0 references

publication date

1 March 2004

1 reference

7 February 2018

European Neuropsychopharmacology

published in

1 reference

7 February 2018

volume

14

1 reference

7 February 2018

page(s)

157-161

1 reference

7 February 2018

issue

2

1 reference

7 February 2018

CCK-4-induced calcium mobilization in T cells is enhanced in panic disorder.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900103-2

7 January 2021

Cholecystokinin tetrapeptide-induced calcium mobilization in T cells of patients with panic disorder, major depression, or schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900103-2

7 January 2021

Enhanced sensitivity to cholecystokinin tetrapeptide in panic disorder. Clinical and behavioral findings

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900103-2

7 January 2021

The panicogenic effects of cholecystokinin-tetrapeptide are antagonized by L-365,260, a central cholecystokinin receptor antagonist, in patients with panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900103-2

7 January 2021

Noradrenergic mechanisms in stress and anxiety: I. Preclinical studies

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900103-2

7 January 2021

The CCK-B antagonist CI-988 increases dopamine levels in microdialysate from the rat nucleus accumbens via a tetrodotoxin- and calcium-independent mechanism.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900103-2

7 January 2021

Anxiolytic effects of CCK-B antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900103-2

7 January 2021

Behavioral profile of CCK2 receptor-deficient mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900103-2

7 January 2021

Cholecystokinin tetrapeptide induces panic-like attacks in healthy volunteers. Preliminary findings.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900103-2

7 January 2021

Development of a class of selective cholecystokinin type B receptor antagonists having potent anxiolytic activity

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900103-2

7 January 2021

Effect of conditioned fear stress on serotonin metabolism in the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900103-2

7 January 2021

Behavioral effects of CCKB receptor ligands in a validated simulation of panic anxiety in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900103-2

7 January 2021

V1 vasopressin receptor antisense oligodeoxynucleotide into septum reduces vasopressin binding, social discrimination abilities, and anxiety-related behavior in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900103-2

7 January 2021

Antisense oligonucleotide inhibition of tryptophan hydroxylase activity in mouse brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900103-2

7 January 2021

A cholecystokinin-B receptor antagonist potentiates GABAergic and glycinergic inhibition in the nucleus of the solitary tract of the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900103-2

7 January 2021

G protein-coupled cholecystokinin-B/gastrin receptors are responsible for physiological cell growth of the stomach mucosa in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900103-2

7 January 2021

The behavioural properties of CI-988, a selective cholecystokininB receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900103-2

7 January 2021

Peptoid CCK receptor antagonists: pharmacological evaluation of CCKA, CCKB and mixed CCKA/B receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900103-2

7 January 2021

Selective loss of delta opioid analgesia and binding by antisense oligodeoxynucleotides to a delta opioid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900103-2

7 January 2021

Suppression of conditioned fear by administration of CCKB receptor antagonist PD135158.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900103-2

7 January 2021

Suppression of conditioned fear by administration of CCKB receptor antisense oligodeoxynucleotide into the lateral ventricle.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900103-2

7 January 2021

Cholecystokinin in anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900103-2

7 January 2021

Cholecystokinin receptor family. Molecular cloning, structure, and functional expression in rat, guinea pig, and human

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900103-2

7 January 2021

Cholecystokinin antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900103-2

7 January 2021

Increased anxiety behavior in OLETF rats without cholecystokinin-A receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900103-2

7 January 2021

Effects of conditioned fear stress on 5-HT release in the rat prefrontal cortex.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2803%2900103-2

7 January 2021

10.1016/S0924-977X(03)00103-2

Identifiers

DOI

1 reference

7 February 2018

PubMed ID

15013032

1 reference

7 February 2018